Protective effect of sevoflurane on hepatic ischaemia/reperfusion injury in the rat: A dose-response study

European Journal of Anaesthesiology

Volumn 30, Issue 10, 2013, Pages 612-617

  Zhou, Shao Peng ^a   Jiang, Ping ^a   Liu, Lu ^a   Liu, Hua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; MALONALDEHYDE; MYELOPEROXIDASE; PENTOBARBITAL; SCAVENGER; SEVOFLURANE; SUPEROXIDE DISMUTASE; BIOLOGICAL MARKER; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; PEROXIDASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATORY CELL; LIVER CELL; LIVER ISCHEMIA; LIVER PROTECTION; LIVER SINUSOID; LIVER STRUCTURE; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; RAT; REPERFUSION INJURY; ANIMAL; BLOOD; CELL PROTECTION; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; LIVER; METABOLISM; PATHOLOGY; PROTECTION; SPRAGUE DAWLEY RAT; TIME; VASCULARIZATION;

ALANINE TRANSAMINASE; ANESTHETICS, INHALATION; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIOMARKERS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER; MALE; MALONDIALDEHYDE; METHYL ETHERS; PEROXIDASE; PROTECTIVE FACTORS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 84884471775     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e3283614023     Document Type: Article

References (10)

1. Ringden O, Labopin M, Gorin Nc, et al. Treatment with granulocyte colonystimulating factor after allogenic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the acute leukemia working party of the European group for blood and marrow transplantation. J Clin Oncol 2004; 22:416-423. (Pubitemid 41079769)
2. Imai M, Kon S, Inaba H. Effects of halothane, isoflurane, and sevoflurane on ischemia-reperfusion injury in the perfused liver of fasted rats. Acta Anaesthesiol Scand 1996; 40:1241-1248.
3. Yamada F, Saito T, Abe T, et al. Ischemic preconditioning enhances regenerative capacity of hepatocytes in long-term ischemically damaged rat livers. J Gastroenterol Hepatol 2007; 22:1971-1977. (Pubitemid 47525072)
4. Novalija E, Kevin LG, Eels JT, et al. Anesthetic preconditioning improves adenosine triphosphate synthesis and reduces reactive oxygen species formation in mitochondria after ischemia by a redox dependent mechanism. Anesthesiology 2003; 98:55-63.
5. Bedirli N, Ofluoglu E, Kerem M, et al. Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model. Anesth Analg 2008; 106:830-837. (Pubitemid 351301403)
6. Beck-Schimmer B, Breitenstein S, Urech S, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008; 248:909-918.
7. Kehl F, Krolikowski JG, Mraovic B, et al. Is isoflurane-induced preconditioning dose related? Anesthesiology 2002; 96:675-680. (Pubitemid 34193509)
8. Soubhia AF, Lauz S, Montero EF, et al. Effects of the inhalational anesthetics halothane and sevoflurane on an experimental model of hepatic injury. Rev Bras Anestesiol 2011; 61:591-603.
9. Frink EJ Jr. The hepatic effects of sevoflurane. Anesth Analg 1995; 81:46-50.
10. Zhou SP, Yang LK, Xiao XY, et al. Effect of sevoflurane on liver and kidney functions of patients during closed circuit anesthesia. Chin J Anes 2009; 29:31-33.